CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Alfresa Holdings Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Alfresa Holdings Corporation
23F, Ote Center Bldg., 1-1-3, Ote-machi
Phone: +81 352195100p:+81 352195100 CHIYODA-KU, TKY  100-0004  Japan Ticker: 27842784
Business Summary
Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
3841 Surgical and medical instruments and apparatus
6411 Insurance agents, brokers, and service
2835 In vitro and in vivo diagnostic substances
2834 Pharmaceutical preparations
4225 General warehousing and storage
5912 Drug stores and proprietary stores
6531 Real estate agents and managers
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Representative Director RyujiArakawa 50 6/1/2020 6/1/2007
President of Subsidiary, Director HisashiKatsuki 67 1/1/2021 6/1/2017
Chairman & President of Subsidiaries, Director KoichiShimada 65 6/1/2018 6/1/2018
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Tokiwa Yakuhin Co Ltd. 860-1, Tsumazakigaisaku Ube Japan

Business Names
Business Name
2784
Alfresa Healthcare Corporation
Alfresa Holdings Corporation
Tokiwa Yakuhin Co., Ltd.

General Information
Number of Employees: 12,517 (As of 3/31/2024)
Outstanding Shares: 186,902,938 (As of 9/30/2024)
Shareholders: 12,055
Stock Exchange: TYO
Fax Number: +81 352195103


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024